Literature DB >> 27995332

Synthesis of Ni(II) complexes bearing indole-based thiosemicarbazone ligands for interaction with biomolecules and some biological applications.

Jebiti Haribabu1, Kumaramangalam Jeyalakshmi1, Yuvaraj Arun2, Nattamai S P Bhuvanesh3, Paramasivan Thirumalai Perumal2, Ramasamy Karvembu4.   

Abstract

A series of new Ni(II) complexes containing indole-based thiosemicarbazone ligands was synthesized and characterized by elemental analyses, and UV-visible, FT-IR, 1H & 13C NMR and mass spectroscopic techniques. The Ni(II) complexes (1-4) bear the general formula [Ni{C10H9N2NHCSNH(R)}2] where R = hydrogen (1), 4-methyl (2), 4-phenyl (3) and 4-cyclohexyl (4). Molecular structure of ligands (L3 and L4) and complexes (2, 3 and 4) was confirmed by single crystal X-ray crystallography. Four coordinated Ni(II) complexes showed square planar geometry. The interaction of the Ni(II) complexes with calf thymus DNA (CT-DNA) has been evaluated by absorption spectroscopic and ethidium bromide (EB) competitive binding studies, which revealed the intercalative interaction of the complexes with CT-DNA. Gel electrophoresis experiments showed the cleavage of DNA by the complexes without any external agent. Further, the interaction of the complexes with bovine serum albumin (BSA) was investigated using UV-visible, fluorescence and synchronous fluorescence spectroscopic methods, which showed that the complexes could bind strongly with BSA. Molecular docking was employed to understand the binding of the Ni(II) complexes with the molecular target B-DNA, human DNA topoisomerase I and BSA. All the Ni(II) complexes possess high antioxidant activity against 2-2-diphenyl-1-picrylhydrazyl (DPPH) radical and antihaemolytic activity. In addition, in vitro cytotoxicity of the Ni(II) complexes against lung cancer (A549), human breast cancer (MCF7) and mouse embryonic fibroblasts (L929) cell lines was investigated. Complex 4 has high cytotoxicity. The mode of cell death effected by complex 4 has been explored using Hoechst 33258 staining. Nickel(II) complexes of thiosemicarbazone ligands were synthesized and their DNA/protein binding, DNA cleavage and cytotoxicity abilities were studied.

Entities:  

Keywords:  Cytotoxicity; DNA/protein interactions; Indole; Nickel(II) complexes; Thiosemicarbazones

Mesh:

Substances:

Year:  2016        PMID: 27995332     DOI: 10.1007/s00775-016-1424-1

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  65 in total

1.  Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice.

Authors:  Zhi-Gang Yang; Hong-Xiang Sun; Wei-Huan Fang
Journal:  Vaccine       Date:  2005-10-25       Impact factor: 3.641

2.  Dinuclear monointercalating RuII complexes that display high affinity binding to duplex and quadruplex DNA.

Authors:  Chatna Rajput; Ramune Rutkaite; Linda Swanson; Ihtshamul Haq; Jim A Thomas
Journal:  Chemistry       Date:  2006-06-02       Impact factor: 5.236

3.  Novel thiosemicarbazone derivatives as potential antitumor agents: Synthesis, physicochemical and structural properties, DNA interactions and antiproliferative activity.

Authors:  Ivica Dilović; Mirta Rubcić; Visnja Vrdoljak; Sandra Kraljević Pavelić; Marijeta Kralj; Ivo Piantanida; Marina Cindrić
Journal:  Bioorg Med Chem       Date:  2008-03-06       Impact factor: 3.641

4.  Indole-3-carbinol improves survival in lupus-prone mice by inducing tandem B- and T-cell differentiation blockades.

Authors:  Xiao-Jie Yan; Mei Qi; Gloria Telusma; Sophia Yancopoulos; Michael Madaio; Minoru Satoh; Westley H Reeves; Saul Teichberg; Nina Kohn; Karen Auborn; Nicholas Chiorazzi
Journal:  Clin Immunol       Date:  2009-03-10       Impact factor: 3.969

5.  DNA, protein binding, cytotoxicity, cellular uptake and antibacterial activities of new palladium(II) complexes of thiosemicarbazone ligands: effects of substitution on biological activity.

Authors:  P Kalaivani; R Prabhakaran; F Dallemer; P Poornima; E Vaishnavi; E Ramachandran; V Vijaya Padma; R Renganathan; K Natarajan
Journal:  Metallomics       Date:  2011-11-03       Impact factor: 4.526

6.  Quenching of fluorescence by oxygen. A probe for structural fluctuations in macromolecules.

Authors:  J R Lakowicz; G Weber
Journal:  Biochemistry       Date:  1973-10-09       Impact factor: 3.162

7.  In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug.

Authors:  M V Blagosklonny; W S el-Deiry
Journal:  Int J Cancer       Date:  1996-07-29       Impact factor: 7.396

8.  On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex.

Authors:  Xiangshu Xiao; Smitha Antony; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2005-05-05       Impact factor: 7.446

9.  A novel water soluble ligand bridged cobalt(II) coordination polymer of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (isonicotinic) hydrazone: evaluation of the DNA binding, protein interaction, radical scavenging and anticancer activity.

Authors:  Duraisamy Senthil Raja; Nattamai S P Bhuvanesh; Karuppannan Natarajan
Journal:  Dalton Trans       Date:  2012-02-21       Impact factor: 4.390

10.  Biological evaluation of new nickel(II) metallates: Synthesis, DNA/protein binding and mitochondrial mediated apoptosis in human lung cancer cells (A549) via ROS hypergeneration and depletion of cellular antioxidant pool.

Authors:  P Kalaivani; S Saranya; P Poornima; R Prabhakaran; F Dallemer; V Vijaya Padma; K Natarajan
Journal:  Eur J Med Chem       Date:  2014-06-03       Impact factor: 6.514

View more
  7 in total

1.  Structural characterization and antileishmanial activity of newly synthesized organo-bismuth(V) carboxylates: experimental and molecular docking studies.

Authors:  Sohaila Andleeb; Muhammad Khawar Rauf; Syed Sikander Azam; Ihsan-Ul Haq; Muhammad Nawaz Tahir; Naila Zaman
Journal:  J Biol Inorg Chem       Date:  2022-01-04       Impact factor: 3.358

2.  Effective inhibition of insulin amyloid fibril aggregation by nickel(II) complexes containing heterocyclic thiosemicarbazones.

Authors:  Kannayiram Gomathi; Jebiti Haribabu; Sivaraj Saranya; Dasararaju Gayathri; Kumaramangalam Jeyalakshmi; Subramanian Sendilvelan; Cesar Echeverria; Ramasamy Karvembu
Journal:  Eur Biophys J       Date:  2021-08-29       Impact factor: 1.733

3.  Synthesis, Characterization and Biological Activity of Novel Cu(II) Complexes of 6-Methyl-2-Oxo-1,2-Dihydroquinoline-3-Carbaldehyde-4n-Substituted Thiosemicarbazones.

Authors:  Eswaran Ramachandran; Valentina Gandin; Roberta Bertani; Paolo Sgarbossa; Karuppannan Natarajan; Nattamai S P Bhuvanesh; Alfonso Venzo; Alfonso Zoleo; Mirto Mozzon; Alessandro Dolmella; Alberto Albinati; Carlo Castellano; Nuno Reis Conceição; M Fátima C Guedes da Silva; Cristina Marzano
Journal:  Molecules       Date:  2020-04-17       Impact factor: 4.411

4.  Synthesis of Palladium(II) Complexes via Michael Addition: Antiproliferative Effects through ROS-Mediated Mitochondrial Apoptosis and Docking with SARS-CoV-2.

Authors:  Jebiti Haribabu; Swaminathan Srividya; Dharmasivam Mahendiran; Dasararaju Gayathri; Vemula Venkatramu; Nattamai Bhuvanesh; Ramasamy Karvembu
Journal:  Inorg Chem       Date:  2020-11-24       Impact factor: 5.165

5.  Experimental and theoretical studies of new Co(III) complexes of hydrazide derivatives proposed as multi-target inhibitors of SARS-CoV-2.

Authors:  Sakineh Parvarinezhad; Mehdi Salehi; Maciej Kubicki; Rahimeh Eshaghi Malekshah
Journal:  Appl Organomet Chem       Date:  2022-08-08       Impact factor: 4.072

Review 6.  Advances in thiosemicarbazone metal complexes as anti-lung cancer agents.

Authors:  Xian-Guang Bai; Yunyun Zheng; Jinxu Qi
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

7.  Design and synthesis of heterocyclic azole based bioactive compounds: Molecular structures, quantum simulation, and mechanistic studies through docking as multi-target inhibitors of SARS-CoV-2 and cytotoxicity.

Authors:  Jebiti Haribabu; Vasavi Garisetti; Rahime Eshaghi Malekshah; Swaminathan Srividya; Dasararaju Gayathri; Nattamai Bhuvanesh; Ramalinga Viswanathan Mangalaraja; Cesar Echeverria; Ramasamy Karvembu
Journal:  J Mol Struct       Date:  2021-10-21       Impact factor: 3.196

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.